Duke Institute for Genome Sciences & Policy, Duke University Medical Center, Durham, NC, USA.
Oncogene. 2012 Nov 1;31(44):4709-17. doi: 10.1038/onc.2011.622. Epub 2012 Jan 16.
The Rb/E2F pathway is deregulated in virtually all human tumors. It is clear that, in addition to Rb itself, essential cofactors required for transcriptional repression and silencing of E2F target genes are mutated or lost in cancer. To identify novel cofactors required for Rb/E2F-mediated inhibition of cell proliferation, we performed a genome-wide short hairpin RNA screen. In addition to several known Rb cofactors, the screen identified components of the Mediator complex, a large multiprotein coactivator required for RNA polymerase II transcription. We show that the Mediator complex subunit MED13L is required for Rb/E2F control of cell growth, the complete repression of cell cycle target genes, and cell cycle inhibition.
Rb/E2F 通路在几乎所有人类肿瘤中都失调。很明显,除了 Rb 本身之外,转录抑制和 E2F 靶基因沉默所必需的必要辅助因子在癌症中发生了突变或丢失。为了鉴定 Rb/E2F 介导的抑制细胞增殖所需的新辅助因子,我们进行了全基因组短发夹 RNA 筛选。除了几种已知的 Rb 辅助因子外,该筛选还鉴定了 Mediator 复合物的成分,Mediator 复合物是一种大型多蛋白共激活因子,是 RNA 聚合酶 II 转录所必需的。我们表明,Mediator 复合物亚基 MED13L 是 Rb/E2F 控制细胞生长、完全抑制细胞周期靶基因和细胞周期抑制所必需的。